For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Imaging isolated and in situ bladder arterioles (Version 1.0) | ATLAS-D2K Center

PLEASE NOTE: ATLAS-D2K closed July 31, 2025 and this website is for reference purposes only.

Imaging isolated and in situ bladder arterioles (Version 1.0)

Version

1.0

Notice

This page is the corresponding protocol tomestone page generated as part of the ATLAS-D2K shutdown in July 2025. Many links on this page may be broken.

Authors

Gerard Ahern

Keywords

[‘immunofluorescence’]

Subjects

[‘Imaging’, ‘Immunological techniques’]

Release Date

2017-08-07

Abstract

Imaging isolated and in situ bladder arterioles protocol by the Ahern Group

Procedure

  • Bladders are removed from TRPV1-Cre:tomato mice, ventrally opened longitudinally from the bladder neck to the top of the dome.
  • Under a dissecting microscope the urothelium is carefully peeled away using iris scissors to expose sub-urothelial arterioles.
  • The preparation is placed in 500 μL of physiological buffer containing 140 mM NaCl, 4 mM KCl, 1 mM MgCl2, 1.2 mM CaCl2, 10 mM HEPES, 5 mM glucose, pH=7.3, and anchored by platinum-wire tissue harps.
  • If desired individual 3rd order arterioles (~20-40 μm diameter) can be carefully microdissected using iris scissors. Isolated arterioles are placed in a micro-insert chamber (Ibidi Inc., volume 10 μL) containing 5 μL of physiological buffer.
  • Stock solutions of capsaicin (1 M and 10 mM in EtOH) and the TRPV1 antagonist, BCTC (2 mM in EtOH) are prepared. From these stocks working solutions of 2 mM (in situ studies) and 10μM (isolated arterioles) capsaicin are prepared. A working solution containing both capsaicin (10μM) and BCTC (2μM) is also prepared.
  • tdTomato is excited at 540±12 nm and emitted florescence is passed through a 620±30 nm bandpass filter. Experiments are digitally recorded at a frame rate of at least 1 per second.
  • Isolated arteries are challenged with 5 μL of 2x capsaicin (10μM) to generate a final concentration of 5μM capsaicin. Subsequently, 5 μL is withdrawn from the chamber and replaced with 5 μL of capsaicin/BCTC (10 μM and 2μM) solution.
  • For in situ preparations a higher capsaicin concentration (~1mM) is required due to the tissue absorption of the drug. 500 μL of 2x (2 mM) capsaicin is added to chamber to yield a final concentration of 1mM capsaicin.
  • At the end of the experiment a solution containing KCl (50 mM) is used as a positive control.
  • Arterial diameter is measured post-hoc at several locations along the artery using the edge-detection plug-in for ImageJ.

Consortium

GenitoUrinary Development Molecular Anatomy Project (GUDMAP) Consortium